AIP
DTIL icon

Almanack Investment Partners’s Precision BioSciences DTIL Stock Holding History

Almanack Investment Partners’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$161K Buy
+20,428
New +$144K 0.02% 305

Other funds holding DTIL

Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CW
CrossGen Wealth Greenville, North Carolina $129M AUM
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
BFS
Beacon Financial Strategies Raleigh, North Carolina $201M AUM 19.14% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Almanack Investment Partners's DTIL Position: Q2 2026 in Review

Almanack Investment Partners opened a new position in Precision BioSciences (DTIL) in Q2 2026: 20,428 shares worth $161K. The stake represents 0.02% of the portfolio and ranks #305 among its holdings.

14 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Almanack Investment Partners held 20,428 shares of Precision BioSciences worth $161K as of Q2 2026.
  • Precision BioSciences was a new Almanack Investment Partners position in Q2 2026.
  • Precision BioSciences made up 0.02% of Almanack Investment Partners's portfolio in Q2 2026, its #305 holding.
  • 14 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Almanack Investment Partners's 13F filing for Q2 2026, filed 30 Jul 2026.